Learn How to Trade Small Cap and Penny Stocks Today!

Good evening Traders,
Many of you email me asking “What is the SuperNova newsletter anyway?” and what is all the hype about?
First of all my newsletter is a dream come true for day traders.

Now, you wonder why my service is great for “day traders?” Well, most of our alerts are bought and sold the following day which means you are not using your “Round trips” so you don’t have to worry about that 3 trade in a 5 day rolling period SEC rule!
Over the past month and a half I have had 21 trade alerts (being a bit cautions with “fiscal cliff chatter) and of those we have had 18 wins and 3 losses.

The winners AND the losers have seen a combined GAIN of 470% which is an average of 23% per trade (that’s with the 3 losers mixed in) with individual day gains of 35%, 53% and 55% all achieved. Our average gain is over 4 to 5 TIMES that of our losing trades.

Now, even if you didn’t grab the bottom and top of each of these alerts but you got just 1/2 of those gains; that would be 235% worth of gains in just under 2 months worth of time.

Other great advantages of the SuperNova Elite program are, you do NOT need to maintain a $25,000 balance as we are trading normal amounts of cash in each trade. We are not a system that puts in $50,000 in a trade looking for 2% which is great for the $50,000 trader but the average $1,000 trader doesn’t even make enough to cover commissions on this type of trade. Our goal is 10 to 20% on a trade and as you can see, several times we are hitting much larger wins!

Now, this is all great for me to tell you about but what are other SuperNova Elite members saying about my service?

Jeff, I set a goal for myself in October to try to make $200 a day. I wanted 12k by the end of December. I work for myself and honestly I am very tired of the grind of constantly chasing clients for money. If I can pull $300 a day, that is enough for me to just daytrade and give up my business. I am proud to say with your help from October to today I have pulled in 29,117.00 which completely crushed my own goal. Thank you for making a difference in my families life ~ Robert
Jeff, ran out of fingers and toes but i made $2,850 on GGR ~ Illgoblind
Jeff, just wanted to say thanks for all the work you and your team of moderators do. My account is now up 450% since August! I am only 21, so this has been an amazing opportunity! So again, thank you! ~ Tanner
Jeff, SRGE sold at 69% percent profit. For a total profit of $6,900.00 thanks again for your valued opinion on the alert. ~ Stephen
Now, if my “buy and sell email/text alerts are not enough for you, let me show you what else you get with my “Elite” membership.
I have been a stock trader for over 16 years and my focus has been on small cap stocks trading which include sub penny stocks, penny stocks and under $3.00 stocks. I hyper trade, day trade, swing trade and occasionally short to medium term trade. You won’t see me holding many “penny stocks” long term because my focus is on making all of us quick money and then moving on.

I am a regular person who loves penny stocks trading. I got burned several years ago listening to “message board” pumps that told me my stock was going to $1.00 when it was trading at $.01 and “buy the dips” while everyone else sold their shares. Yup, been there, done that! Lost my shirt and then some.
So I sat down and for the next year or so I learned how to read charts and understand the little things that make penny stocks tick. Technical indicators, moving averages, market makers, times and sales and anything else I could get my hands on, I studied it for months; in a nut shell I learned it all!

Now I am ready to share my knowledge with you and my goal is to teach you how to become a smarter more profitable investor just like me.

About three to five times a week I will send you an email, cell phone text and chat room alert with one or two action ready stock symbols that I feel are good day-trades, swing trades or sometimes short term trades. The alert will include the company, price targets, stop loss and reasons why I feel this penny stock or cap stock will perform favorably for us in the near future.
I have even gone as far as setting up a “SuperNova” chat room only where members can come and talk to me directly during the morning market hours. Currently we have over 420 “Elite” members in chat with me as I break down stocks live for them as well as give them action ready stocks that are looking ready to produce big gains. Heck just recently I have had stocks of 15% gains, 20% gains, 35% gains and more! Tell me what bank gives you those kinds of returns!

So are you sick and tired of being stuck in every pump and dump stock? Tired of getting in on the top of the run only to lose big bucks? What about not knowing when to enter when the stock pulls back? Can’t read a chart? Don’t know what broker to use?
To subscribe just click on this link right here and hit “Buy Now“ to start getting hot stock alerts sent right to your inbox. It really is THAT EASY. I have even reduced my start up prices to be the best value to you of any other “Penny Stock and Small Cap Stock Newsletter around. Trust me when I say you WON’T find another newsletter that gives you

over 110 online educational video lessons valued at over $7,000 access to the largest live stock chat room on the Internet 5 Week Mentor Program – Free for SuperNova Elite members nightly watch lists of 2 -4 of the highest quality stocks based on technical analysis Did I mention buy and sell text alerts for those at work or not sitting in front of their computers all day? Yes, text alerts, email alerts and 24/7 tech support from myself.
 Source:- http://www.topstockpicks.com/public-category/learn-to-trade-small-cap-and-penny-stocks-today/

Top Brokers for Penny Stock Trading

Looking for a affordable broker to trade penny stocks with that won’t nickel and dime you to death? Its a question I get asked often and since my SuperNova Elite premium newsletter focuses on stocks ranging from $.001 to $5.00, a top penny stock broker is a must!

If I had to recommend one, I would start with Etrade and the reason why is simple. They have a very good “flat fee” commission which is only $9.99 OR $7.99 if you are a active trader; per trade. They don’t add on extra fees for every 1,000 shares over 10,000 for example like some brokers do.

Etrade also has whats called “Etrade Pro” and this is a software program that has a level 2 (Market Depth) a charting program, a live streaming scanner with custom features, live TV, streaming news, quotes and a whole lot more. Assuming you are somewhat active, they will give this to you for free!

Charles Schwab is another broker I would recommend taking a look at. Now I have not been with Schwab in many years but I hear they are very good now for penny stocks. They don’t “restrict” penny stocks like Ameritrade does for example, they let you trade the stock you want just like Etrade does. Their commission is also a “flat fee” and I believe it is similar to Etrade at $9.99 or $7.99

Those are my top 2 penny stock brokers and I would look strongly in to them if you are serious about making big money in the penny stock markets.

Remember, my SuperNova Elite service has been built around 16 years of trading experience for stocks under $5.00 per share and above $.001 or what most would call “small cap stocks.” We have thousands of satisfied subscribers that continue to resubscribe day after day; not to mention refer their friends and family to our service as well.

Source:-http://www.topstockpicks.com/public-category/top-brokers-for-penny-stock-trading/

Cereplast Receives Major Purchase Order; Shares Surge

Cereplast Inc. (OTC: CERP), a company engaged in the development and commercialization of bio-based resins, has seen a sharp rise in its shares in trading today. The rally has been sparked after the company announced the receipt of a $1.4 million purchase order for its Biopropylene® 101.

CERP’s Biopropylene 101 is part of the Cereplast Sustainables® family of resins. The product maintains most of the desirable conventional Polypropylene properties such as chemical resistance, mold shrinkage, mold flow, surface appearance, heat deflection temperature and hinge performance. However, when compared to Polypropylene, Biopropylene provides a lower carbon footprint. Given the increasing demand for environmentally friendly products, Biopropylene has a bright outlook.

Earlier today, Cereplast announced that it received a $1.4 million purchase order for its Biopropylene 101 from Dugar Eximark Private Limited, a Hyderabad, India-based company. The company will sell the material from its existing inventory. The order will be shipped from Europe over the next 10 months.

Commenting on the purchase order, Frederic Scheer, Chairman and CEO of Cereplast, said that entering into an agreement to liquidate existing inventory is a critical milestone for the company. Scheer further said that from a financial perspective, the transaction yields strong cash flow over the next 10 months due to the sale of existing product already manufactured. He added that in the company’s continued effort to build its footprint in India, it is encouraged by the continued partnership it has built with Dugar Eximark.

While the company is building its footprint in India, it is also hoping for positive developments in other parts of the world, especially in Europe. Back in April, the Italian government signed and published a decree inflicting sanctions on bags made from traditional plastics. However, in May, the U.K. government filed an opposition with the European Union (EU), claiming that Italy was breaching EU internal market rules. This has led to some delay.

CEO Scheer noted that the passing of the September 12, 2013 date without an update from the EU has left the EU market in a state of confusion in terms of what the status of the legislation is. Scheer noted that when dealing with a governing body, delays are to be expected. However, he remains confident that there will be resolution in the near-term.

For the first half of 2013, Cereplast reported net revenue of $1.7 million, significantly above the $305,000 reported for the same period in the previous year. In fact, the company’s first half revenue is higher than the revenue reported for the whole of 2012. In 2012, CERP’s total revenue was $911,000.
CERP shares have surged in trading today. At last check, the stock was trading 26.32% higher at $0.0168 on above average volume of 30.32 million.

CERP shares have broken through their 50-day moving average in trading today as a result of the rally. The stock’s MACD has also crossed above the signal line. Both of these are strong bullish signals, and suggest that the upward momentum in CERP shares could continue, going forward.

View to Original post :- Click here

Biotechnology Stock in Focus; Geron Corporation (GERN)

Equities have edged lower in trading today as market participants remain on the sidelines amid concerns over the debt ceiling issue and uncertainty related to QE3. However, shares of Geron Corporation (NASDAQ: GERN) are continuing their upward march in trading. Shares of the biotechnology company have been having an excellent run over the past couple weeks. Based in Menlo Park, California, Geron is a clinical-stage biopharmaceutical company engaged in the development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

The company uses its proprietary nucleic acid chemistry to develop imetelstat as a short, modified oligonucleotide that is a potent and specific inhibitor of telomerase, which is a key target for anti-cancer therapeutics. Imetelstat is the first ever telomerase inhibitor to advance to clinical development.
Geron is currently conducting a Phase 2 trial to evaluate the activity of imetelstat in patients with essential thrombocythemia (ET) or polycythemia vera, who need cytoreduction and have failed or are intolerant to previous therapy or who refuse standard therapy.

In June this year, Geron had announced that updated clinical trial results from its Phase 2 trial of imetelstat in ET were presented in an oral session at the 18th Congress of the European Hematology Association in Stockholm by principal investigator of the trial Prof. Dr. med. Gabriela M. Baerlocher of the University Hospital and University of Bern, Switzerland.

Prof. Baerlocher noted that imetelstat continues to be well tolerated in the trial and with no patients on treatment losing hematologic response and molecular responses maintained in 86% of the patients, the drug also appears to have good durability of its effects on the disease.

Geron is also conducting an investigator-sponsored trial (IST) to evaluate the safety and efficacy of imetelstat in patients with myelofibrosis (MF) and to determine an appropriate dose and schedule for further evaluation. The trial was initiated by Dr. Ayalew Tefferi at Mayo Clinic in November 2012 based on data from the Phase 2 clinical trial of imetelstat in patients with ET.

Last month, Geron had also reported its second-quarter financial results. For the quarter ended June 30, 2013, GERN reported a net loss of $8.9 million, or $0.07 per share, compared to $18.3 million, or $0.14 per share reported for the same period in the previous year. The company’s net loss for the first six months of 2013 stood at $20.8 million, or $0.16 per share, compared to $37.1 million, or $0.29 per share reported for the same period in the previous year.

At the end of the second quarter of 2013, GERN had $71.6 million in cash and investments on its balance sheet.

GERN shares have been gaining momentum over the past couple of weeks. Since September 9, the stock has gained nearly 97%. In today’s trading, the stock is up 23.49% to $3.05 on above average volume of 4.31 million. The stock struck a 52-week high of $3.07 earlier in the day.
GERN shares have seen a series of higher highs in the last two weeks. The stock’s MACD chart suggests that the upward momentum could continue in the near-term. However, given the progress Geron has made in its clinical trials, the stock is an excellent play in the long-term as well.

View to Original post:- Click here

Big Mover on The Nasdaq; Towerstream Corporation (TWER)

Shares of Towerstream Corporation (NASDAQ: TWER), a provider of broadband services to commercial customers, have risen sharply in trading today. TWER shares have been boosted by M&A news in the telecom sector. The sharp rise in trading today has helped TWER shares break through some key technical levels. Technical indicators suggest that the upward momentum in TWER shares could continue.

Earlier today, two major deals were announced in the telecom sector. Verizon Communications (NYSE: VZ) announced that it will acquire Vodafone Group Plc’s (ADR) (NASDAQ: VOD) 45% stake in Verizon Wireless, the joint venture between VZ and VOD. Meanwhile, Microsoft Corp. (NASDAQ: MSFT) announced that it will acquire Nokia Corporation’s (ADR) (NYSE: NOK) handset business.

News of the deals lifted shares in the telecom sector, including those of Towerstream Corporation. However, TWER shares are also gaining as the stock’s technical indicators are giving bullish signals.

TWER shares have surged after the stock entered oversold territory recently. At last check, TWER shares were up 8.60% to $2.40 on volume of 192,643. The stock broke through $2.30 resistance level earlier in the day. It also broke through $2.40 resistance level before paring some of the gains. The stock’s MACD is about to cross over the signal line. This is a strong bullish signal. In addition, the stock is also about to establish a “golden cross”, with the 50-day moving average about to cross the 200-day moving average.

Once the 50-day moving average crosses the 200-day moving average, there could be significant gains.
TWER shares could break through $2.40 and $2.50 resistance levels in the next few trading sessions. TWER shares could see a pullback from around $2.70. Certainly, there is significant upside potential from current level.

Last month, Towerstream had reported its financial results for the second quarter ended June 30, 2013. For the quarter, the company reported revenue of $8.21 million, compared to $8.10 million reported for the same period in the previous year. The company’s consolidated gross margin for the quarter was 35%, compared to 54% reported for the same period in the previous year. Churn rate was 2.37% during the second quarter of 2013, compared to 1.65% reported for the same period in the previous year. ARPU stood at $740, compared to $708.

At the end of second quarter of 2013, the company signed a long-term Wi-Fi lease agreement with a major cable operator. Jeffrey Thompson, President and CEO of Towerstream, said that securing the first anchor tenant for TWER’s neutral host network is a major milestone and validates the company’s rent-based business model. Thompson further said that the company expects to continue to expand its Wi-Fi customer base over the balance of the year, while preparing for the impending rollout of small cell.

According to Joseph Hernon, CFO of Towerstream, small cell technologies, including Wi-Fi, will allow service providers and platform players to differentiate their offering, add new services, and improve the user experience in dense urban markets where demand levels are pressuring network capacity.

View to Original post :- Click Here

Smaller Trading Account, Check out This Service

Welcome to the #1 Rated Penny Stock Newsletter 2 Years Running

Hello Traders, Just a FYI 12 hours left to SAVE $150 off SuperNova Elite before prices rise. (click here for full description of service and price details) One of the most commonly asked questions I get from the Free List is “Can I use just $500 or $1,000 with your service?

Listen, I totally understand that money is tight now days but you want a service that will work for your smaller account. Well, listen to the comment from Sharon which she just posted to me in the chat room.
Jeff, I would like to quickly thank you before I leave for the evening. I have checked out many services but none of them worked for my trading account. I only had about $600 to start with and while other services were making big profits, it wouldn’t equal ANY profit for my smaller account size. Anyway, I decided to join and today alone, my trading account went from $600 to $870 dollars due to your AMBS text message alert. Now my focus will be on a smaller percent gain due to my larger bank roll.

 I am so happy I found your service and I look forward to being with you a long time. Enjoy your family and extra day off, you deserve it!

Well there ya go! The point is, YES I know of other services out there that are awesome for bigger accounts, but MY SuperNova Elite service works BEST for traders from $500 to $50,000 accounts.
If you have a $500 account you can focus on my $.001 to $.10 cent stocks – which see the biggest % gains.
If you have a $5,000 to $50,000 account you can pretty much play ALL my trades under $5.00 – solid gains but bigger profits with larger position size!

Listen, the longer you sit and watch the more profits you miss. I am here to help you not only make MORE profits but to LEARN why you are making all this extra cash. If I can teach you how and why we are making trades, then you can start to duplicate it on your own!

SuperNova Elite Gives You Buy and sell emails Buy and sell text message alerts Price of alerts $.001 to $5.00 Scalp Trades Swing Trades Short Term Trades 105 Educational Video Lessons – More learning material than any other service Live Stock Chat Room 6 Moderators that specialize in a variety of areas Nightly Stock Scans Portfolio Analysis of our trades Weekly Seminars 24/7 Email Support
View to Original post :- Click Here

Turn $800 into $50,000 Trading Penny Stocks

Welcome to the #1 Rated Penny Stock Newsletter 2 Years Running In

 4 days my pricing goes up nearly $150 per quarter – Act now and SAVE! Earlier today I showed you how one trader specifically turned $4k into $25k following my advice.

 I understand not all traders have $4k to start, but what about $800? I just wanted to say thanks for what you’ve done with the chat room the past week in regards to cleaning it up. It’s much more focused and is just a great place to be! Also, I saw on the front page the story about royal and his success and I too wanted to say thank you for helping me grow my account.

At the middle of last summer I had hit rock bottom in both my trading confidence and my account. I had a total of $800. So, I took you advice and watched all of your videos and made sure to watch how you and other good traders traded in the chat room. Needless to say, that $800 is now over $50,000 and growing. That’s including taking out money for college (Which we all know ain’t cheap), paying for an engagement ring, and other expenses.
So, again, thank you so much for all you do! This service is the best and I am not going anywhere! Keep up the incredible work! – Tanner Metrics and results don’t lie, nor does my service! Come September my SuperNova Elite price will be rising nearly $150 per quarter and my SuperNova Combo will be rising nearly $200 per quarter.

View to Original post :- Click Here

Big Mover on the Nasdaq; Genetic Technologies Limited (GENE)

U.S. equity market has rebounded sharply in trading today as market sentiment has been lifted by some positive economic data from Europe and China. All three major indexes have risen sharply. Among the biggest gainers on the Nasdaq today is Genetic Technologies Limited (ADR) (NASDAQ: GENE), an Australia-based company providing genetic testing services.

GENE shares are surging after the company today said that its wholly-owned subsidiary Phenogen Sciences Inc. executed an agreement with InterWest Health of Missoula, Montana, U.S. to use the InterWest provider network. A regional provider, InterWest Health services seven states in north-west U.S. The states include Montana, Idaho and Washington.

 This is the eighth such agreement executed between GENE and similar U.S. Preferred Provider Organizations (PPOs). Apart from InterWest Health, the company has executed agreements with FedMed Inc., MultiPlan Network, Three Rivers Provider Network, Prime Health Services, National Preferred Provider Network/PlanCare America/Ohio Preferred Network LLC, Galaxy Health Network and Fortified Provider Network. These agreements are certainly benefiting GENE as evidenced by the company’s performance during the quarter ended June 30, 2013. During the quarter, the company received a record number of BREVAGen™ test samples. Total patient samples received during the quarter stood at 599, which represents growth of over 48% on a quarter-over-quarter basis.

 For the first six months of 2013, total BREVAGen™ test samples received stood at 1,547, which represents a growth of over 272% on a year-over-year basis.

 GENE, recently, also executed a merger agreement with Sydney-based Simavita Holdings Limited. The agreement was executed by the company’s Canadian-listed subsidiary, Gtech International Resources Limited. Gene Technologies CEO Alison Mew said that the company is extremely pleased that Gtech entered into a transaction that will see all of its shareholders, including GENE, benefit from the planned expansion of the exciting Simavita business into the huge North American market and beyond. Mew also said that the transition of management to the incoming Simavita team will allow Genetic Technologies to maintain focus on the expansion of its U.S. business through the growth of its flagship BREVAGen™ test.

Apart from these positive developments, GENE is also expected to benefit from an increase in demand for genetic testing. According to a study conducted by the research arm of UnitedHealth Group, spending on genetic testing in the U.S. alone is expected to be between $15 billion and $25 billion by 2021. UnitedHealth expects double digit growth over the next few years. GENE, with its recent developments, is certainly well-positioned to capitalize on this growth. Not surprisingly, the company’s shares have been seeing increasing interest from investors.

 GENE shares have surged in trading today, striking an intra-day high of $2.81. At last check, the stock was trading 24.09% higher at $2.73. The rally today has pushed GENE shares above their 50-and 200-day moving averages, which is a strong bullish signal. The bullish trend is further confirmed by the MACD chart. The MACD has crossed over the signal line. GENE shares are expected to face resistance at around $2.80. If the stock breaks through this level then the next resistance level will be at around $3.
View to Original post :- Click Here

Big Mover on the Nasdaq; NF Energy Saving Corp. (NFEC)

China-based NF Energy Saving Corp. (NASDAQ: NFEC) today announced the signing of an energy service contract in Dongguan, China. The announcement sent NFEC shares sharply higher.

NF Energy Saving, which manufactures large diameter energy efficient flow control systems for a range of industries in China, signed an energy efficiency service contract with Dongguan Xianjia Plastic Products Company. The contract was signed through Liaoning NF Energy, which is NFEC’s wholly-owned subsidiary.

Under the terms of the contract, NFEC will retrofit 58 units of Dongguan Xianjia’s injection molding machines, which will result in energy saving of up to 40%. The contract certainly highlights the increasing demand for energy efficient products and services in China. In the last few years, the Chinese government has also pushed for energy saving products and services. This certainly augurs well for NFEC.
Last week, NF Energy Saving had reported its financial results for the second quarter ended June 30, 2013. For the quarter, the company’s total revenue stood at $1.47 million. For the first six months of 2013, the company’s revenue stood at $2.77 million.

NFEC’s gross profit for the second quarter stood at $0.43 million. For the six-month period ended June 30, 2013, NFEC reported a gross profit of $0.84 million. Net income for the second quarter was $52,017, while for the first half of 2013 it was $61,782.

Earlier this month, NF Energy Saving also announced the establishment of a new subsidiary, NF Energy Corporation Guangdong Subsidiary. The subsidiary has been established in Guangzhou, China. Through the subsidiary, the company is looking to improve the development of its energy saving products and enable it to take advantage of the expanding energy saving industry in China.

Given all these positive developments, it is not surprising that NFEC shares have been significant interests from investors recently. The stock surged 22.63% to finish at $2.33 in trading today after striking a 52-week high of $2.88. NFEC shares have now gained more than 86% in just the last three trading sessions. The stock is nearly 250% in the last one month. Year-to-date, the stock has gained more than 129%.
The gains in the last one month have pushed NFEC shares above their 50-day and 200-day moving averages. This is a strong bullish signal. The stock’s MACD chart further confirms the bullish trend. The MACD is currently trading above the signal line as well as the zero-line. Also, the MACD histogram is indicating increasing upward momentum. Certainly, technical indicators suggest that market sentiment is bullish on the stock at the moment.

While technical indicators point to further gains in NFEC shares in the near-term, the increasing demand for energy saving products and services in China makes NFEC an excellent long-term bet as well. Also, the recent developments at NFEC suggest that the company is well-positioned to capitalize on the increasing demand for energy products and services in China. All these make NFEC a stock to watch in the long-term as well.
View to Original post:Click Here

Automakers Near 52-Week High

U.S. automakers Ford Motor Company (NYSE: F) and General Motors Company (NYSE: GM) are hovering around their 52-week high as improving U.S. auto sales are continuing to benefit the two companies. Last week, a report showed that auto sales rose to pre-crisis level in the month of July. Both Ford and GM registered a sharp rise in July U.S. auto sales

While Ford registered an 11% increase in U.S. auto sales, GM posted a 16% increase in sales. More importantly, the outlook for U.S. auto sales remains robust.One of the major factors behind improving auto sales has been increasing demand for pickup trucks, which is being driven by an ongoing improvement in the economy.

Last week, a data from the Commerce Department showed that the U.S. economy grew more than forecast in the second quarter of 2013, while manufacturing activity accelerated in the month of July.
 The big question is whether you should buy automakers at current levels. The answer is probably yes as the recovery in the auto market is expected to continue, benefiting both Ford and GM. In terms of valuation, both Ford and GM are looking attractive right. Ford is trading on a P/E ratio of just 11.52, while GM is currently trading on a P/E ratio of 13.25. Given these factors, there is certainly further upside potential in automaker
 Original post :- Click here